Abiopharma

News list

Director Hertz Walter Marc 🟢 acquired 26.7K shares (1 derivative) of GRI Bio, Inc. (GRI) at $1.41 Transaction Date: Aug 26, 2025 | Filing ID: 000144

Full text

News bot Aug. 27, 2025, 12:26 p.m.
🔍 Hertz Walter Marc (Director)

Company: GRI Bio, Inc. (GRI)

Report Date: 2025-08-26
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 26,688
Detailed Transactions and Holdings:
- Acquired 26,688 shares of Stock Option (Right to Buy) at $1.41 per share (Derivative)
  Date: 2025-08-26 | Code: A | Expires: 2035-08-26 | equity_swap_involved: 0 | shares_owned_after: 26,688.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Options to purchase 17,828 shares vested in full upon the date of grant and options to purchase 8,860 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant.